U Power Limited Expands European Presence with UOTTA Technology Implementation in Portugal
-Energy U Limited,Subsidiary of U Power,Forms Joint Venture to Deploy Battery Swapping Solutions- SHANGHAI,Jan. 6,2025-- U Power Limited (Nasdaq: UCAR) (the "Company" or "U Power")
AUKEY UNVEILS TWO NEW PRODUCTS IN AWARD-WINNING MAGFUSION LINE AT CES
Showcaseswireless chargers designed to tackle overheating issues,CES Innovation Award winning mobile phone accessories
DREO Brings Motion-Tracking Air Comfort and AI Chef Assistant to CES 2025
CLIFTON,N.J.,Jan. 7,2025-- DREO,the No. 1 fan and heater brand in the U.S. and proud recipient of theTIME Best Inventions 2024award for its groundbreaking kitchen innovation,is set to unveil a series
Yaber at CES 2025: Color the Movie Night
Enjoy Stunning Visuals with Yaber\'s Powerful K300s,L2 Plus,and T2 Series LAS VEGAS,Jan. 7,2025-- Yaber,a pioneer in entertainment projectors,introduces three groundbreaking models: the ultra-short t
WuXi Biologics Announces Agreement with Candid Therapeutics on Trispecific T-cell Engager
SHANGHAI and SAN DIEGO,Jan. 7,2025-- WuXi Biologics ("WuXi Bio") (2269. HK),a leading global Contract Research,Development,and Manufacturing Organization (CRDMO),today announced an agreement
ROHM Develops 1kW-class High-power Infrared Laser Diode
-125W × 8-channel High-power Array Significantly Improves Measurement Distance and Resolution inLiDAR Applications-
CHANGZHOU,China,Jan. 7,2025-- Recently,the grid service pilot project of State Grid Changzhou Power Supply Company has demonstrated remarkable success. On January 7,with the proactive assistance of th
Huion Unveils Mid-to-High-End 2.5K Pen Display Kamvas 16 (Gen 3) at CES 2025
LAS VEGAS,Jan. 7,2025-- Huion,a leading brand in digital drawing technology,is debuting the Kamvas 16 (Gen 3) at CES 2025. This continues Huion\'s tradition of showcasing new products at CES. Kamvas
GORTEC Announces New Trial Success for Head and Neck Cancer Treatment
TOURS,France,Jan. 7,2025-- GORTEC,known as Head and Neck Radiation Oncology Group,today announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab,Bristol Myers Squibb
MedicosBiotech Wins CES 2025 Innovation Award in Digital Health
SEOUL,South Korea,Jan. 8,2025-- MedicosBiotech proudly announces its recognition at CES 2025,the world\'s premier technology event,as a recipient of the prestigious CES Innovation Award in the Digital